G. Fuglsang et al., INFLUENCE OF BUDESONIDE ON THE RESPONSE TO INHALED TERBUTALINE IN CHILDREN WITH MILD ASTHMA, Pediatric allergy and immunology, 6(2), 1995, pp. 103-108
The aim of this study was to evaluate if continuous treatment with bud
esonide or salmeterol influences the bronchodilator response to terbut
aline in children with asthma; 23 children, aged 7 to 16 years (mean =
11 years), with mild asthma were treated with inhaled budesonide 100
mu g b.i.d; and placebo for three weeks in a randomized, double blind
crossover study. These treatments were followed by treatment with inha
led salmeterol 50 mu g b.i.d. for 3 weeks. On the last day of each per
iod a cumulative dose-response experiment with terbutaline in the dose
s 50, 100, 250 and 500 mu g (cumulative dose 900 mu g) was performed.
Lung function was measured before and 20 min after each terbutaline in
halation. Baseline pulmonary functions after budesonide treatment were
significantly higher than the baseline measured after the two other t
reatments (p<0.05). After budesonide treatment, the dose-response curv
e was shifted vertically upwards but otherwise parallel to the dose-re
sponse curve after placebo. The increase from baseline after the first
cumulative dose of terbutaline was significantly lower after salmeter
ol treatment than after the two other treatments (p<0.01). Maximal lun
g functions after 900 mu g terbutaline also differed significantly bet
ween the three dose-response days; budesonide being significantly high
er and salmeterol significantly lower than placebo (p=0.02 and p<0.001
, respectively). It is concluded that budesonide treatment does not en
hance the brochodilator response to terbutaline. Further studies are n
eeded to assess if long-term continuous salmeterol treatment reduces t
he response to terbutaline.